English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
ERSAP Diagnosis & Testing Program
Diagnosis and Testing Program 2014
iCMLf Diagnosis and Testing Program: Apply for 2014 grants
The iCMLf Diagnosis and Testing Program launched in 2011 offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in developing countries where it is not currently available.
Building on the success of the current program and the nine projects awarded iCMLf grants, the Foundation will offer further grants in 2014. These iCMLf grants are for projects that will increase local access to CML diagnostics.
Grants are available to physicians, scientists and hematology laboratory staff working in a hospital or research institution. Building local capacity and resource sustainability are important criteria for this iCMLf funding.
Diagnostic testing and monitoring for CML patients globally: The next challenge for the iCMLf
Improving access to CML diagnostic testing and monitoring globally
Improving access to diagnostics is one of the most challenging issues to address on a large scale. Through small grants and partnerships with CML centres of excellence the ERSAP Diagnosis and Testing Program plans to enable centres in emerging regions to increase their local capacity to conduct diagnostic and long term monitoring of their CML patients. We hope that, for the first time in many cases, physicians will be able to locally confirm the diagnosis of CML patients, leading to better treatment and long term care. This has the potential to dramatically alter the lives of the patients and their families, in some cases whole communities.
